• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia

05/05/2017 by Catherine Saez, Intellectual Property Watch 2 Comments

According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia’s tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a “confidential interim report” has been circulated. Australia is not commenting.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, English, Health & IP, Health Policy Watch, IP Law, Trademarks/Geographical Indications/Domains, WTO/TRIPS

WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs

04/05/2017 by Catherine Saez, Intellectual Property Watch 6 Comments

A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Health Policy Watch, Human Rights, Lobbying, Patents/Designs/Trade Secrets, WHO

WHO Project To Prequalify Biosimilar Cancer Medicines Aims At Increased Affordability

04/05/2017 by Intellectual Property Watch 1 Comment

The World Health Organization announced today that it will launch a pilot project in 2017 for prequalifying cancer biosimilar medicines, with the intent of lowering prices on some of the most expensive cancer treatments.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Health Policy Watch, Patents/Designs/Trade Secrets, WHO

  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Top Global Health stories

New WHO Director Tedros’s Opening Vision: People First

Enter The African Medicines Agency, Continent’s First Super-Regulator?

More health stories...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting